Know Labs, Inc. (KNW)

NYSEAMERICAN: KNW · IEX Real-Time Price · USD
1.92
+0.05 (2.67%)
Oct 6, 2022 9:30 AM EDT - Market open
2.67%
Market Cap 84.02M
Revenue (ttm) 4.36M
Net Income (ttm) -22.10M
Shares Out 43.76M
EPS (ttm) -0.75
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 33,514
Open 1.91
Previous Close 1.87
Day's Range 1.85 - 1.92
52-Week Range 1.76 - 3.17
Beta 2.37
Analysts n/a
Price Target n/a
Earnings Date n/a

About KNW

Know Labs, Inc. focuses on the development and commercialization of proprietary technologies in the United States. Its technology uses spectroscopy to direct electromagnetic energy through a substance or material to capture a molecular signature. The company refers to its technology as Bio-RFID. The Bio-RFID technology can be integrated into various wearable, mobile, or bench-top form factors. Its first application of Bio-RFID technology is a product marketed as a glucose monitor that provide the user with real time information on their blood g... [Read more...]

Industry Electronic Equipment, Instruments & Components
Founded 1998
CEO Phillip Bosua
Employees 15
Stock Exchange NYSEAMERICAN
Ticker Symbol KNW
Full Company Profile

Financial Performance

Financial Statements

News

Know Labs, Inc. Announces Closing of $8.28 Million Public Offering of Common Stock

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the closing of its underwritten public offering of 4,...

2 weeks ago - Business Wire

Know Labs (KNW) Stock Falls on IPO

Shares of Know Labs (NYSE: KNW ) are trading messily on Friday. The stock is down about 18% so far on the day, as investors size up the current environment.

2 weeks ago - InvestorPlace

Know Labs, Inc. Announces Pricing of Upsized $7.2 Million Public Offering of Common Stock and Uplisting to the NYSE A...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (NYSE American: KNW), an emerging developer of non-invasive medical diagnostic technology, today announced the pricing of a firm commitment underwritten public ...

2 weeks ago - Business Wire

Know Labs, Inc. Announces NYSE American Listing Approval

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTCQB: KNWN), an emerging leader of non-invasive medical diagnostic technology, today announced that, subject to official authorization and meeting all require...

3 weeks ago - Business Wire

Know Labs Provides Update on IRB-Approved Internal Trial of Non-Invasive Glucose Monitoring Technology

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTCQB: KNWN), an emerging developer of non-invasive medical diagnostic technology, today released a video update on the IRB-approved internal trial the Company...

1 month ago - Business Wire

Know Labs Files S-1 for New Share Offering, Seeks Uplist to NYSE American Exchange

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTCQB: KNWN) an emerging developer of non-invasive medical diagnostic technology, today announced it has filed a Form S-1 registration statement for a proposed...

2 months ago - Business Wire

Know Labs Expands Leadership Team, Adds Chief Financial Officer and Chief Product Officer, As It Gets Closer to FDA C...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostic technology, today announced the addition of two senior executives, each of whom will play a...

4 months ago - Business Wire

Know Labs, Inc. Discusses Significance of Patented Non-Invasive Blood Glucose Monitoring Technology with The Stock Da...

Phoenix, Arizona--(Newsfile Corp. - May 10, 2022) - The Stock Day Podcast welcomed Know Labs, Inc. (OTCQB: KNWN) ("the Company"), a company that is transforming non-invasive medical diagnostics. The com...

4 months ago - Newsfile Corp

New Foundational Patents Secure Multiple Growth Opportunities for Know Labs and Its Bio-RFID™ Non-Invasive Diagnostic...

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced it has been granted two new foundational patents that add significant val...

6 months ago - Business Wire

Know Labs Provides 2022 Outlook, Outlines Preparations for Pre-Submission Meeting with FDA

SEATTLE--(BUSINESS WIRE)--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today provided an update on its outlook for 2022, as the company executes its plan to bri...

6 months ago - Business Wire

Know Labs Receives IRB Approval to Begin Internal Clinical Trial of Non-Invasive Glucose Monitoring Technology Bio-RFID™

SEATTLE--(BUSINESS WIRE)---- $KNWN #KnowLabs--Know Labs, Inc. (OTCQB: KNWN), an emerging leader in non-invasive medical diagnostics, today announced it has received approval from an independent Institut...

8 months ago - Business Wire

Insiders Buying Pixelworks And 4 Other Penny Stocks

The Euro surged to $1.13 against the US dollar this morning after recent data showed the Eurozone inflation increased to a new record high of 5.1% in January. Investors, meanwhile, focused on some notab...

Other symbols: PXLWAXDXEPZMJSDA
8 months ago - Benzinga